HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
E Fenig Selected Research
E Fenig Research Topics
Disease
6
Neoplasms (Cancer)
01/2022 - 02/2000
6
Breast Neoplasms (Breast Cancer)
06/2007 - 05/2000
2
Ewing Sarcoma (Sarcoma, Ewing)
06/2007 - 05/2005
2
Melanoma (Melanoma, Malignant)
05/2005 - 02/2000
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2001 - 02/2001
2
Airway Obstruction (Choking)
05/2001 - 03/2000
2
Hodgkin Disease (Hodgkin's Disease)
02/2001 - 05/2000
2
Neoplasm Metastasis (Metastasis)
04/2000 - 02/2000
1
Kaposi Sarcoma (Kaposi's Sarcoma)
01/2022
1
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2006
1
Inflammatory Breast Neoplasms
12/2002
1
Necrosis
05/2001
1
Second Primary Neoplasms (Neoplasms, Second)
04/2001
1
Dermatitis
03/2001
1
Congenital Abnormalities (Deformity)
02/2001
1
Merkel Cell Carcinoma
02/2000
1
Sarcoma (Soft Tissue Sarcoma)
01/2000
Drug/Important Bio-Agent (IBA)
2
Imatinib Mesylate (Gleevec)
FDA Link
06/2007 - 05/2005
1
B7-H1 Antigen
IBA
01/2022
1
DNA (Deoxyribonucleic Acid)
IBA
01/2022
1
Ipilimumab
IBA
01/2022
1
Nivolumab
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
01/2022
1
Cisplatin (Platino)
FDA Link
Generic
06/2007
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
11/2001
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
11/2001
1
Transforming Growth Factor beta (TGF-beta)
IBA
11/2001
1
Ointments (Pastes)
IBA
03/2001
1
Lipiderm
IBA
03/2001
1
Biafine
IBA
03/2001
1
Biological Products
IBA
02/2000
1
Etoposide (VP 16)
FDA Link
Generic
02/2000
1
Topoisomerase II Inhibitors
IBA
02/2000
1
Pharmaceutical Preparations
IBA
02/2000
1
Gemcitabine
FDA Link
01/2000
1
Ifosfamide
FDA Link
Generic
01/2000
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2000
Therapy/Procedure
4
Radiotherapy
01/2006 - 05/2000
2
Segmental Mastectomy (Lumpectomy)
01/2006 - 12/2002
2
Drug Therapy (Chemotherapy)
12/2002 - 01/2000
2
Brachytherapy
05/2001 - 03/2000
2
Palliative Care (Palliative Therapy)
05/2001 - 03/2000
2
Lymph Node Excision (Lymph Node Dissection)
04/2000 - 02/2000
1
Conservative Treatment
01/2006
1
Induction Chemotherapy
12/2002
1
Aftercare (After-Treatment)
04/2001
1
Contraindications
02/2001
1
Prophylactic Mastectomy
05/2000
1
Catheters
03/2000
1
Bronchoscopes
03/2000